{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:19:11Z","timestamp":1773663551087,"version":"3.50.1"},"reference-count":53,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB\/TRR57, projects P13 and Q3"],"award-info":[{"award-number":["SFB\/TRR57, projects P13 and Q3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at the RWTH Aachen University","award":["O3-1"],"award-info":[{"award-number":["O3-1"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>This Special issue contains 48 contributions highlighting novel findings and current concepts in basic and clinical liver fibrosis research. These articles emphasize issues on pathogenesis, cellular mediators, modulators, molecular pathways, disease-specific therapies, scoring systems, as well as novel preclinical animal models for the study of liver fibrogenesis. This editorial aims to briefly summarize the content of these papers.<\/jats:p>","DOI":"10.3390\/cells9051105","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T13:23:45Z","timestamp":1588166625000},"page":"1105","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Special Issue on \u201cCellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis\u201d"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3888-0931","authenticated-orcid":false,"given":"Ralf","family":"Weiskirchen","sequence":"first","affiliation":[{"name":"Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, D-52074 Aachen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,4,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"F1000 Faculty Rev-921","DOI":"10.12688\/f1000research.14841.1","article-title":"Recent Advances in Understanding Liver Fibrosis: Bridging Basic Science and Individualized Treatment Concepts","volume":"7","author":"Weiskirchen","year":"2018","journal-title":"F1000Research"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3389\/fphar.2015.00303","article-title":"Hepatoprotective and Anti-Fibrotic Agents: It\u2019s Time to Take the Next Step","volume":"6","author":"Weiskirchen","year":"2016","journal-title":"Front. Pharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mam.2018.06.003","article-title":"Organ and Tissue Fibrosis: Molecular Signals, Cellular Mechanisms and Translational Implications","volume":"65","author":"Weiskirchen","year":"2019","journal-title":"Mol. Aspects Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Roehlen, N., Crouchet, E., and Baumert, T.F. (2020). Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells, 9.","DOI":"10.3390\/cells9040875"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Drescher, H., Weiskirchen, S., and Weiskirchen, R. (2019). Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH). Cells, 8.","DOI":"10.3390\/cells8080845"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Khatun, M., and Ray, R. (2019). Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis. Cells, 8.","DOI":"10.3390\/cells8101249"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Gerresheim, G., Roeb, E., Michel, A., and Niepmann, M. (2019). Hepatitis C Virus Downregulates Core Subunits of Oxidative Phosphorylation, Reminiscent of the Warburg Effect in Cancer Cells. Cells, 8.","DOI":"10.3390\/cells8111410"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Ninio, L., Nissani, A., Meirson, T., Domovitz, T., Genna, A., Twafra, S., Srikanth, K., Dabour, R., Avraham, E., and Davidovich, A. (2019). Virus Enhances the Invasiveness of Hepatocellular Carcinoma via EGFR-Mediated Invadopodia Formation and Activation. Cells, 8.","DOI":"10.3390\/cells8111395"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Chen, D., Le, T., Shahidipour, H., Read, S., and Ahlenstiel, G. (2019). The Role of Gut-Derived Microbial Antigens on Liver Fibrosis Initiation and Progression. Cells, 8.","DOI":"10.3390\/cells8111324"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Gottlieb, A., and Canbay, A. (2019). Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression. Cells, 8.","DOI":"10.3390\/cells8111358"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Klindt, C., Reich, M., Hellwig, B., Stindt, J., Rahnenf\u00fchrer, J., Hengstler, J., K\u00f6hrer, K., Schoonjans, K., H\u00e4ussinger, D., and Keitel, V. (2019). The G Protein-Coupled Bile Acid Receptor TGR5 (Gpbar1) Modulates Endothelin-1 Signaling in Liver. Cells, 8.","DOI":"10.3390\/cells8111467"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Kaya, D., Kaji, K., Tsuji, Y., Yamashita, S., Kitagawa, K., Ozutsumi, T., Fujinaga, Y., Takaya, H., Kawaratani, H., and Moriya, K. (2019). TGR5 Activation Modulates an Inhibitory Effect on Liver Fibrosis Development Mediated by Anagliptin in Diabetic Rats. Cells, 8.","DOI":"10.3390\/cells8101153"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Hohenester, S., Kanitz, V., Kremer, A., Paulusma, C., Wimmer, R., Kuehn, H., Denk, G., Horst, D., Oude Elferink, R., and Beuers, U. (2020). Glycochenodeoxycholate Promotes Liver Fibrosis in Mice with Hepatocellular Cholestasis. Cells, 9.","DOI":"10.3390\/cells9020281"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Ming, Y., Zhu, X., Tuma-Kellner, S., Ganzha, A., Liebisch, G., Gan-Schreier, H., and Chamulitrat, W. (2019). iPla2\u03b2 Deficiency Suppresses Hepatic ER UPR, Fxr, and Phospholipids in Mice Fed with MCD Diet, Resulting in Exacerbated Hepatic Bile Acids and Biliary Cell Proliferation. Cells, 8.","DOI":"10.3390\/cells8080879"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Inoue, M., Nakatsu, Y., Yamamotoya, T., Hasei, S., Kanamoto, M., Naitou, M., Matsunaga, Y., Sakoda, H., Fujishiro, M., and Ono, H. (2019). Pin1 Plays Essential Roles in NASH Development by Modulating Multiple Target Proteins. Cells, 8.","DOI":"10.3390\/cells8121545"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Mahli, A., Seitz, T., Freese, K., Frank, J., Weiskirchen, R., Abdel-Tawab, M., Behnam, D., and Hellerbrand, C. (2019). Therapeutic Application of Micellar Solubilized Xanthohumol in a Western-Type Diet-Induced Mouse Model of Obesity, Diabetes and Non-Alcoholic Fatty Liver Disease. Cells, 8.","DOI":"10.3390\/cells8040359"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Wang, P., Wu, T., Lin, T., Chen, M., Yeh, C., and Pan, T. (2019). Characterization of the Roles of Vimentin in Regulating the Proliferation and Migration of HSCs during Hepatic Fibrogenesis. Cells, 8.","DOI":"10.3390\/cells8101184"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Foglia, B., Sutti, S., Pedicini, D., Cannito, S., Bocca, C., Maggiora, M., Bevacqua, M., Rosso, C., Bugianesi, E., and Albano, E. (2020). A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts. Cells, 9.","DOI":"10.3390\/cells9010028"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ignat, S., Dinescu, S., Hermenean, A., and Costache, M. (2020). Cellular Interplay as a Consequence of Inflammatory Signals Leading to Liver Fibrosis Development. Cells, 9.","DOI":"10.3390\/cells9020461"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Rossato, M., Di Vincenzo, A., Pagano, C., El Hadi, H., and Vettor, R. (2020). The P2X7 Receptor and NLRP3 Axis in Non-Alcoholic Fatty Liver Disease: A Brief Review. Cells, 9.","DOI":"10.3390\/cells9041047"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Reyes-Gordillo, K., Shah, R., Arellanes-Robledo, J., Cheng, Y., Ibrahim, J., and Tuma, P. (2019). Akt1 and Akt2 Isoforms Play Distinct Roles in Regulating the Development of Inflammation and Fibrosis Associated with Alcoholic Liver Disease. Cells, 8.","DOI":"10.3390\/cells8111337"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Puente, A., Fortea, J., Del Pozo, C., Huelin, P., Cagigal, M., Serrano, M., Cabezas, J., Arias Loste, M., Iruzubieta, P., and Cuadrado, A. (2019). Porto-Sinusoidal Vascular Disease Associated to Oxaliplatin: An Entity to Think about It. Cells, 8.","DOI":"10.3390\/cells8121506"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Schmidt-Arras, D., and Rose-John, S. (2019). Regulation of Fibrotic Processes in the Liver by ADAM Proteases. Cells, 8.","DOI":"10.3390\/cells8101226"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Hintermann, E., and Christen, U. (2019). The Many Roles of Cell Adhesion Molecules in Hepatic Fibrosis. Cells, 8.","DOI":"10.3390\/cells8121503"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Sommer, J., Dorn, C., G\u00e4bele, E., Bataille, F., Freese, K., Seitz, T., Thasler, W., B\u00fcttner, R., Weiskirchen, R., and Bosserhoff, A. (2020). Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver Injury. Cells, 9.","DOI":"10.3390\/cells9010248"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Seo, H., Lee, S., Lee, J., Kang, Y., Choi, Y., Hwang, J., Park, K., Jang, B., and Kim, M. (2019). Clusterin Attenuates Hepatic Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Downregulating the Smad3 Signaling Pathway. Cells, 8.","DOI":"10.3390\/cells8111442"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Melgar-Lesmes, P., Perramon, M., and Jim\u00e9nez, W. (2019). Roles of the Hepatic Endocannabinoid and Apelin Systems in the Pathogenesis of Liver Fibrosis. Cells, 8.","DOI":"10.3390\/cells8111311"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Chang, M., and Yang, S. (2019). Metabolic Signature of Hepatic Fibrosis: From Individual Pathways to Systems Biology. Cells, 8.","DOI":"10.3390\/cells8111423"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Khomich, O., Ivanov, A., and Bartosch, B. (2020). Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis. Cells, 9.","DOI":"10.3390\/cells9010024"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Zhou, W., Yang, Y., Mei, C., Dong, P., Mu, S., Wu, H., Zhou, Y., Zheng, Y., Guo, F., and Yang, J. (2019). Inhibition of Rho-Kinase Downregulates Th17 Cells and Ameliorates Hepatic Fibrosis by Schistosoma japonicum Infection. Cells, 8.","DOI":"10.3390\/cells8101262"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"K\u00f6se-Vogel, N., Stengel, S., Gardey, E., Kirchberger-Tolstik, T., Reuken, P., Stallmach, A., and Bruns, T. (2020). Transcriptional Suppression of the NLRP3 Inflammasome and Cytokine Release in Primary Macrophages by Low-Dose Anthracyclines. Cells, 9.","DOI":"10.3390\/cells9010079"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Milito, A., Brancaccio, M., D\u2019Argenio, G., and Castellano, I. (2019). Natural Sulfur-Containing Compounds: An Alternative Therapeutic Strategy against Liver Fibrosis. Cells, 8.","DOI":"10.3390\/cells8111356"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Lambrecht, J., Verhulst, S., Reynaert, H., and van Grunsven, L. (2019). The miRFIB-Score: A Serological miRNA-Based Scoring Algorithm for the Diagnosis of Significant Liver Fibrosis. Cells, 8.","DOI":"10.3390\/cells8091003"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Lin, H., Wang, F., Yang, Y., and Huang, Y. (2019). MicroRNA-29a Suppresses CD36 to Ameliorate High Fat Diet-Induced Steatohepatitis and Liver Fibrosis in Mice. Cells, 8.","DOI":"10.3390\/cells8101298"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Lachiondo-Ortega, S., Mercado-G\u00f3mez, M., Serrano-Maci\u00e1, M., Lopitz-Otsoa, F., Salas-Villalobos, T., Varela-Rey, M., Delgado, T., and Mart\u00ednez-Chantar, M. (2019). Ubiquitin-Like Post-Translational Modifications (Ubl-PTMs): Small Peptides with Huge Impact in Liver Fibrosis. Cells, 8.","DOI":"10.3390\/cells8121575"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Lee, C., Kim, J., and Jung, Y. (2019). Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease\/Nonalcoholic Steatohepatitis. Cells, 8.","DOI":"10.3390\/cells8101259"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Kaur, S., Rawal, P., Siddiqui, H., Rohilla, S., Sharma, S., Tripathi, D., Baweja, S., Hassan, M., Vlaic, S., and Guthke, R. (2019). Increased Expression of RUNX1 in Liver Correlates with NASH Activity Score in Patients with Non-Alcoholic Steatohepatitis (NASH). Cells, 8.","DOI":"10.3390\/cells8101277"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Mahli, A., Seitz, T., Beckr\u00f6ge, T., Freese, K., Thasler, W., Benkert, M., Dietrich, P., Weiskirchen, R., Bosserhoff, A., and Hellerbrand, C. (2019). Bone Morphogenetic Protein-8B Expression is Induced in Steatotic Hepatocytes and Promotes Hepatic Steatosis and Inflammation In Vitro. Cells, 8.","DOI":"10.3390\/cells8050457"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Malik, A., Sim\u00f5es, I., Rosa, H., Khan, S., Karkucinska-Wieckowska, A., and Wieckowski, M. (2019). A Diet Induced Maladaptive Increase in Hepatic Mitochondrial DNA Precedes OXPHOS Defects and May Contribute to Non-Alcoholic Fatty Liver Disease. Cells, 8.","DOI":"10.3390\/cells8101222"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Pinheiro, D., Dias, I., Ribeiro Silva, K., Stumbo, A., Thole, A., Cortez, E., de Carvalho, L., Weiskirchen, R., and Carvalho, S. (2019). Mechanisms Underlying Cell Therapy in Liver Fibrosis: An Overview. Cells, 8.","DOI":"10.3390\/cells8111339"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Levada, K., Omelyanchik, A., Rodionova, V., Weiskirchen, R., and Bartneck, M. (2019). Magnetic-Assisted Treatment of Liver Fibrosis. Cells, 8.","DOI":"10.3390\/cells8101279"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1073\/pnas.1222878110","article-title":"Inflammation and Host Response to Injury, Large Scale Collaborative Research Program. Genomic responses in mouse models poorly mimic human inflammatory diseases","volume":"110","author":"Seok","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Maeso-D\u00edaz, R., Boyer-Diaz, Z., Lozano, J., Ortega-Ribera, M., Peralta, C., Bosch, J., and Gracia-Sancho, J. (2019). New Rat Model of Advanced NASH Mimicking Pathophysiological Features and Transcriptomic Signature of the Human Disease. Cells, 8.","DOI":"10.3390\/cells8091062"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Hempel, F., Roderfeld, M., Savai, R., Sydykov, A., Irungbam, K., Schermuly, R., Voswinckel, R., K\u00f6hler, K., Churin, Y., and Kiss, L. (2019). Depletion of Bone Marrow-Derived Fibrocytes Attenuates TAA-Induced Liver Fibrosis in Mice. Cells, 8.","DOI":"10.3390\/cells8101210"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Guldiken, N., Hamesch, K., Schuller, S., Aly, M., Lindhauer, C., Schneider, C., Fromme, M., Trautwein, C., and Strnad, P. (2019). Mild Iron Overload as Seen in Individuals Homozygous for the Alpha-1 Antitrypsin Pi*Z Variant Does Not Promote Liver Fibrogenesis in HFE Knockout Mice. Cells, 8.","DOI":"10.3390\/cells8111415"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.20427","article-title":"A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations","volume":"40","author":"Magness","year":"2004","journal-title":"Hepatology"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Krenkel, O., Hundertmark, J., Ritz, T., Weiskirchen, R., and Tacke, F. (2019). Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis. Cells, 8.","DOI":"10.3390\/cells8050503"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Li, X., Chen, R., Kemper, S., and Brigstock, D. (2020). Dynamic Changes in Function and Proteomic Composition of Extracellular Vesicles from Hepatic Stellate Cells during Cellular Activation. Cells, 9.","DOI":"10.3390\/cells9020290"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Weiskirchen, R., Meurer, S., Liedtke, C., and Huber, M. (2019). Mast Cells in Liver Fibrogenesis. Cells, 8.","DOI":"10.3390\/cells8111429"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"El Hadi, H., Di Vincenzo, A., Vettor, R., and Rossato, M. (2020). Relationship between Heart Disease and Liver Disease: A Two-Way Street. Cells, 9.","DOI":"10.3390\/cells9030567"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Buniatian, G., Weiskirchen, R., Weiss, T., Schwinghammer, U., Fritz, M., Seferyan, T., Proksch, B., Glaser, M., Lourhmati, A., and Buadze, M. (2020). Antifibrotic Effects of Amyloid-Beta and Its Loss in Cirrhotic Liver. Cells, 9.","DOI":"10.3390\/cells9020452"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Schwinghammer, U., Melkonyan, M., Hunanyan, L., Tremmel, R., Weiskirchen, R., Borkham-Kamphorst, E., Schaeffeler, E., Seferyan, T., Mikulits, W., and Yenkoyan, K. (2020). \u03b12-Adrenergic Receptor in Liver Fibrosis: Implications for the Adrenoblocker Mesedin. Cells, 9.","DOI":"10.3390\/cells9020456"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Ghallab, A., Myllys, M., Holland, C.H., Zaza, A., Murad, W., Hassan, R., A. Ahmed, Y., Abbas, T., Abdelrahim, E.A., and Schneider, K. (2019). Influence of Liver Fibrosis on Lobular Zonation. Cells, 8.","DOI":"10.3390\/cells8121556"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/5\/1105\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:24:06Z","timestamp":1760361846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/5\/1105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,29]]},"references-count":53,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5]]}},"alternative-id":["cells9051105"],"URL":"https:\/\/doi.org\/10.3390\/cells9051105","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,29]]}}}